Sunshine Lake Pharma Co., Ltd.
Clinical trials sponsored by Sunshine Lake Pharma Co., Ltd., explained in plain language.
Sunshine Lake Pharma is a Chinese pharmaceutical company developing innovative drugs and generics.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Healthy men needed to test new Injection's safety Results expected Sep 2026 (estimated)
- New pill HEC585 aims to slow lung scarring in rare disease Results expected Dec 2026 (estimated)
- New pill targets RET-Driven cancers in early trial Results expected Dec 2026 (estimated)
- Liver health may change how cancer drug works Results expected Dec 2026 (estimated)
- Healthy volunteers needed to test safety of experimental NASH drug Results expected Dec 2026 (estimated)